MarketLens
Sign Up

Why is Boston Scientific Acquiring Penumbra

8 months ago
SHARE THIS ON:

Why is Boston Scientific Acquiring Penumbra

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Boston Scientific Leans on Acquisitions to Drive Long-Term Growth

Boston Scientific is leaning on acquisitions to expand into high-growth markets, with the Penumbra deal adding a major thrombectomy opportunity. The strategy aims to drive long-term growth, though no ...
Stock News•2 months ago

Why Boston Scientific Stock Crashed Today

Boston Scientific's stock fell after the company disclosed a global cybersecurity incident disrupting operations, with the investigation ongoing and the nature, scope, and impact still undetermined.
Stock News•2 months ago

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Boston Scientific CEO Michael Mahoney bought ~200,000 shares for ~$10.0 million on August 3, 2026, at $48.34, raising his total equity holdings by 13%. The insider purchase signals management confiden...

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•2 hours ago

Stock Market Today, Nov. 4: Amazon Jumps 6% From New Perspective on AWS Growth and AI Strategy Following Election Results

Stock News•2 hours ago

Apple (AAPL)) Price Forecast: Record High Follows Dramatic Reversal

Stock News•2 hours ago

Apple cements its status as tech's biggest heavyweight with the stock's best day in over a year

Stock News•3 hours ago

Here's What a $1,000 Investment in AMD Could Be Worth by 2030